Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from General Clinical Specialties: Endocrinology

  • You have access
    Has come the day to do away with thyroid remnant ablation targeting 300 gray (Gy)?
    Mario Medvedec and Damir Dodig
    Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 16P;
  • You have access
    Evaluation of the role of F-18 FDG PET in differentiated thyroid cancer with low and high thyroglobulin levels
    Partha Sinha and Gary Conrad
    Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 16P;
  • You have access
    A relationship between F-18 FDG hypermetabolism and progression of pulmonary nodular disease in differentiated thyroid carcinoma
    Gary Conrad and Partha Sinha
    Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 16P;
  • You have access
    Prevention of radiation sialadenitis and glossitis after radioiodine-131 therapy of thyroid cancer
    Edward Silberstein
    Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 14P;
  • You have access
    Bone metastases of differentiated thyroid cancer: Impact of early 131I-based detection on outcome
    Elif Hindie, Paolo Zanotti-Fregonara, Isabelle Keller, Jean-Yves Devaux, Marie Calzada-Nocaudie, Jean-Luc Moretti and Marie-Elisabeth Toubert
    Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 15P;
  • You have access
    Thyroglobulin measurement in monitoring response to radioiodine treatment in children with differentiated thyroid carcinoma (DTC) and lung metastases
    Daria Handkiewicz-Junak, Jozef Roskosz, Jolanta Krajewska, Aleksandra Kukulska, Aleksandra Kropinska, Renata Deja, Zbigniew Puch and Barbara Jarzab
    Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 17P;
  • You have access
    Is radioiodine therapy necessary in small (≤ 1 cm) papillary and follicular thyroid carcinoma?
    Burkhard Riemann, Vera Hutzenlaub and Otmar Schober
    Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 15P;
  • You have access
    Survival in patients with metastatic differentiated thyroid carcinoma
    Kim Biermann, Janina Raddatz, Holger Brockmann, Holger Palmedo, Samer Ezziddin, Jan Bucerius, Hojjat Ahmadzadehfar and Hans-Juergen Biersack
    Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 14P;
  • You have access
    Radioiodide imaging and therapy of anaplastic thyroid cancer transfected with human sodium iodide symporter coupled with lentiviral system
    Chien-Chih Ke, Ren-Shyan Liu, Fu-Hui Wang and Ya-Ju Hsieh
    Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 18P;
  • You have access
    The utility of radioiodine whole body scans prior to 131-I ablation in patients with well-differentiated thyroid cancer
    Douglas Van Nostrand, Marta Aiken, Frank Atkins, Giuseppe Esposito, Shari Moreau, Carlos Garcia, Elmo Acio, Kenneth Burman and Leonard Wartofsky
    Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 15P;

Pages

  • Previous
  • Next
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
SNMMI

© 2025 SNMMI

Powered by HighWire